Julie R. Brahmer

Publishes on Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics. 854 papers and 124.6k citations.

PubIndex Score98Top 2%How it's scored

🌟#2 Current Senior Leader in Cancer Immunotherapy and Biomarkers

854Publications

124.6kTotal Citations

#2in Cancer Immunotherapy and Biomarkers

First publication: 1998First senior author: 2005

Cancer Immunotherapy and Biomarkers Lung Cancer Treatments and Mutations Cancer Genomics and Diagnostics Lung Cancer Research Studies Lung Cancer Diagnosis and Treatment

Top publicationsby citations

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

Suzanne L. Topalian, Mario Sznol, F. Stephen Hodi et al.|New England Journal of Medicine|2012

Cited by 12.6k

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

Julie R. Brahmer, Jon M. Wigginton, Scott S. Tykodi et al.|New England Journal of Medicine|2012

Cited by 8k

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline

Julie R. Brahmer, John A. Thompson, Christina Lacchetti et al.|Journal of Clinical Oncology|2018

Cited by 3.7k

Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab

Suzanne L. Topalian, F. Stephen Hodi, Mario Sznol et al.|Journal of Clinical Oncology|2014

Cited by 2.2k

Neoadjuvant PD-1 Blockade in Resectable Lung Cancer

Patrick M. Forde, Drew M. Pardoll, Jamie E. Chaft et al.|New England Journal of Medicine|2018

Cited by 2.1k